We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Protocol For The Quantitation Of Pain In The Diagnosis Of Polymyalgia Rheumatica

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00847236
Recruitment Status : Completed
First Posted : February 19, 2009
Last Update Posted : August 23, 2017
Information provided by (Responsible Party):
Lahey Clinic

Brief Summary:
The aim of this study is to evaluate a simple and rapid method in order to better define and treat Polymyalgia Rheumatica by measuring levels of muscle achiness and pain with a blood pressure cuff.

Condition or disease
Polymyalgia Rheumatica Rheumatoid Arthritis Rheumatic Disease

Detailed Description:

This study is being conducted to evaluate a method for the quantifying of the proximal tenderness in patients with presumed diagnosis of Polymyalgia Rheumatica(PMR)using the measurements of pain thresholds(in both upper and lower arms) by the use of a standard blood pressure cuff.

At the present time the diagnosis of PMR is based upon four classic criteria, History of sudden onset symmetric painful proximal myopathy, Physical demonstrating proximal tenderness without loss of motion passively, Laboratory evidence of significant inflammation: ESR>50 and treatment with a rapidly beneficial response to low dose prednisone.

While the history, laboratory findings, and the response to prednisone are easily documented, the complaint of tenderness and the physical response to that tenderness is difficult to define and quantitate.

By better quantifying the tenderness and the physical response to that tenderness will, it is hoped, lead to more rapid diagnosis as well as improved approach to treatment.

Three groups of patients will be studied. Each patient, after written informed consent and procedure statement, will have pain threshold measurements taken and recorded by standard blood pressure cuff 4 times: one each on the lower and upper arms. The blood pressure cuff will be inflated to the level of maximum pain, then deflated, recording the maximum pain level. Absolute numbers will be used for each measurement. Blood pressure will not be recorded.

This study is an attempt to add definition to the diagnosis of Polymyalgia Rheumatica with a both simple and rapid office exam.

Study Type : Observational
Actual Enrollment : 142 participants
Observational Model: Case-Control
Time Perspective: Prospective
Official Title: Protocol For The Quantitation Of Pain In The Diagnosis Of Polymyalgia Rheumatica
Actual Study Start Date : January 2009
Primary Completion Date : August 2013
Study Completion Date : August 2013

Subjects with Polymyalgia Rheumatica
50 subjects with Polymyalgia Rheumatica, both acute and chronic
Subjects w/o Polymyalgia Rheumatica
50 subjects with Rheumatic Disease other than polymyalgia Rheumatica
Subjects w/o Rheumatic Disease
50-Non Rheumatic disease subjects

Primary Outcome Measures :
  1. To define whether the measurement of proximal arm tenderness can be used to diagnose and treat patients with Polymyalgia Rheumatica [ Time Frame: One to two visits each subject ]

Secondary Outcome Measures :
  1. Assessing the ease of measuring proximal arm tenderness [ Time Frame: One to two visits each subject ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   50 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Outpatients and Healthy volunteers from colleague referral and own practice

Inclusion Criteria:

  • Patients signing Informed Consent

Exclusion Criteria:

  • Patients less than 50 years old

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00847236

United States, Massachusetts
Lahey Arlington
Arlington, Massachusetts, United States, 02474
Sponsors and Collaborators
Lahey Clinic
Principal Investigator: Gerald S. Harris, M.D. Lahey Clinic, Inc. Arlingtion

Responsible Party: Lahey Clinic
ClinicalTrials.gov Identifier: NCT00847236     History of Changes
Other Study ID Numbers: 2008-078
First Posted: February 19, 2009    Key Record Dates
Last Update Posted: August 23, 2017
Last Verified: August 2017

Keywords provided by Lahey Clinic:
Polymyalgia Rheumatica
Rheumatoid Arthritis
Rheumatic Disease

Additional relevant MeSH terms:
Arthritis, Rheumatoid
Rheumatic Diseases
Collagen Diseases
Polymyalgia Rheumatica
Giant Cell Arteritis
Joint Diseases
Musculoskeletal Diseases
Connective Tissue Diseases
Autoimmune Diseases
Immune System Diseases
Muscular Diseases
Vasculitis, Central Nervous System
Autoimmune Diseases of the Nervous System
Nervous System Diseases
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases
Skin Diseases, Vascular
Skin Diseases